Hydrocodone chemical structure
Find information on thousands of medical conditions and prescription drugs.

Lortab

Hydrocodone or dihydrocodeinone (marketed as Vicodin, Anexsia, Dicodid, Hycodan, Hycomine, Lorcet, Lortab, Norco, Tussionex, Vicoprofen) is an opioid derived from either of the naturally occurring opiates codeine or thebaine. Hydrocodone is an orally active narcotic analgesic and antitussive. The typical therapeutic dose of 5 to 10 mg is pharmacologically equivalent to 30 to 60 mg of oral codeine. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
Labetalol
Lacrisert
Lactitol
Lactuca virosa
Lactulose
Lamictal
Lamisil
Lamivudine
Lamotrigine
Lanophyllin
Lansoprazole
Lantus
Lariam
Larotid
Lasix
Latanoprost
Lescol
Letrozole
Leucine
Leucovorin
Leukeran
Levaquin
Levetiracetam
Levitra
Levocabastine
Levocetirizine
Levodopa
Levofloxacin
Levomenol
Levomepromazine
Levonorgestrel
Levonorgestrel
Levophed
Levora
Levothyroxine sodium
Levoxyl
Levulan
Lexapro
Lexiva
Librium
Lidocaine
Lidopen
Linezolid
Liothyronine
Liothyronine Sodium
Lipidil
Lipitor
Lisinopril
Lithane
Lithobid
Lithonate
Lithostat
Lithotabs
Livostin
Lodine
Loestrin
Lomotil
Loperamide
Lopressor
Loracarbef
Loratadine
Loratadine
Lorazepam
Lortab
Losartan
Lotensin
Lotrel
Lotronex
Lotusate
Lovastatin
Lovenox
Loxapine
LSD
Ludiomil
Lufenuron
Lupron
Lutropin alfa
Luvox
Luxiq
Theophylline
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Sales and production of this drug have increased significantly in recent years, as have diversion and illicit use. Hydrocodone is commonly available in tablet, capsule and syrup form.

As a narcotic, hydrocodone relieves pain by binding to opioid receptors in the brain and spinal cord. It may be taken with or without food, but should never be combined with alcohol. It may interact with monoamine oxidase inhibitors, as well as other drugs that cause drowsiness. It is in FDA pregnancy category C: its effect on an unborn embryo or fetus is not clearly known and pregnant women should consult their physicians before taking it. Common side effects include dizziness, lightheadedness, nausea, drowsiness, euphoria, vomiting, and constipation. Some less common side effects are allergic reaction, blood disorders, changes in mood, mental fogginess, anxiety, lethargy, difficulty urinating, spasm of the ureter, irregular or depressed respiration and rash.

Hydrocodone can be habit-forming, and can lead to physical and psychological addiction. In the U.S., pure hydrocodone and forms containing more than 15 mg per dosage unit are called hydrocodone compounds and are considered Schedule II drugs. Those containing less than 15 mg per dosage unit are Schedule III drugs. Hydrocodone is typically found in combination with other drugs such as paracetamol (acetaminophen), aspirin, ibuprofen and homatropine methylbromide. In the UK it is listed as a Class A drug under the Misuse of Drugs Act 1971.

The presence of acetaminophen in hydrocodone-containing products deters many drug users from taking excessive amounts. However, some users will get around this by extracting a portion of the acetaminophen using hot/cold water, taking advantage of the water-soluble element of the drug. It is not uncommon for addicts to have liver problems from taking excessive amounts of acetaminophen over a long period of time--taking 10–15 grams of acetaminophen in a period of 24 hours typically results in severe hepatotoxicity. It is this factor that leads many addicts to use only single entity opiates such as OxyContin.

Symptoms of hydrocodone overdosage include respiratory depression, extreme somnolence, coma, stupor, cold and/or clammy skin, sometimes bradycardia, and hypotension. A severe overdose may involve circulatory collapse, cardiac arrest and/or death.

How Supplied

Notes

  1. ^  Tarascon Pocket Pharmacopoeia.

Read more at Wikipedia.org


[List your site here Free!]


Youths Report Decline In Use Of LSD, Marijuana And Ecstasy In U.S. Survey
From Juvenile Justice Digest, 9/20/04

Use of illicit drugs including marijuana, ecstasy and LSD by youth declined significantly last year.

The 2003 National Survey on Drug Use and Health released by the Substance Abuse and Mental Health Services Administration (SAMHSA) found an increased perception of risk of marijuana.

But illicit drug use for adults in 2003 stayed about the same as in the previous survey.

Current consumption of marijuana plummeted nearly 30 percent among 12 to 13 year-olds.

There is also a 5 percent decline in the number of youths aged 12 to 17 who have ever used marijuana.

In addition, use of ecstasy and LSD dropped a significantly for youth aged 12-17, including 41 percent for ecstasy and 54 percent for LSD.

There's also a 20 percent decline between 2002 and 2003 in the number of youth claiming to be "heavy users" of marijuana (those smoking either daily or 20 or more days per month). Perceived availability of the drug also declined significantly among youth.

For the general population, the report added there was no significant change in the category "current use of any illicit drug". Overall, 19.5 million Americans ages 12 and older, or 8 percent of this population, currently use illicit drugs.

The survey found that of the 19.4 million adults (age 18 and over) used or were dependent on alcohol or drugs (19.4 million) in 2003.

For youth, SAMHSA attributes the increased perception of marijuana risk to anti-drug messages parental disapproval of substance use and positive attitudes about school

Marijuana continues to be the most commonly used illicit drug, with 14.6 million current users (6.2 percent of the population). The study cites an estimated 2.6 million new marijuana users in 2002. About two thirds of these were under age 18, and about half were female.

There were an estimated 2.3 million persons who used cocaine in 2003 including 604,000 crack users.

One million persons used hallucinogens, including LSD, PCP, ecstasy and other substances, and 119,000 people were estimated to currently use heroin.

These projections are all similar to estimates for these drugs in 2002, the government said.

The non-medical lifetime use of prescription pain relievers showed a 5 percent increase for the population 12 and older, with young adults (18-25) experiencing a 15 percent increase in lifetime, as well as current use.

Over all, current use of prescription pain relievers non-medically remained stable from 2002-2003. There was a statistically significant increase in lifetime non-medical use of Vicodin, Lortab, or Lorcet from 13.1 million to 15.7 million.

Inf.: National Survey on Drug Use and Health, www.oas.samhsa.gov.

Copyright Washington Crime News Service Sep 20, 2004
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Lortab
Home Contact Resources Exchange Links ebay